Bibliography
Found 105 results
Filters: Keyword is HIV-1 [Clear All Filters]
Cocaine potentiates cathepsin B secretion and neuronal apoptosis from HIV-infected macrophages. J Neuroimmune Pharmacol. 2014 ;9(5):703-15.
. Epigenetic alterations in the brain associated with HIV-1 infection and methamphetamine dependence. PLoS One. 2014 ;9(7):e102555.
. Expression of the mannose receptor CD206 in HIV and SIV encephalitis: a phenotypic switch of brain perivascular macrophages with virus infection. J Neuroimmune Pharmacol. 2014 ;9(5):716-26.
. Heme oxygenase-1 deficiency accompanies neuropathogenesis of HIV-associated neurocognitive disorders. J Clin Invest. 2014 ;124(10):4459-72.
. . ING116070: a study of the pharmacokinetics and antiviral activity of dolutegravir in cerebrospinal fluid in HIV-1-infected, antiretroviral therapy-naive subjects. Clin Infect Dis. 2014 ;59(7):1032-7.
. Polyamines: Predictive Biomarker for HIV-Associated Neurocognitive Disorders. Journal of AIDS & Clinical Research. 2014 ;5(6).
. . Molecular and pathologic insights from latent HIV-1 infection in the human brain. Neurology. 2013 ;80(15):1415-23.
. Wnt signaling in the pathogenesis of human HIV-associated pain syndromes. Journal of neuroimmune pharmacology: the official journal of the Society on NeuroImmune Pharmacology [Internet]. 2013 ;8(4):956-64. Available from: http://www.ncbi.nlm.nih.gov/pubmed/23737037
. Genetic features of cerebrospinal fluid-derived subtype B HIV-1 tat. J Neurovirol. 2012 ;18(2):81-90.
Higher HIV-1 genetic diversity is associated with AIDS and neuropsychological impairment. Virology. 2012 ;433(2):498-505.
Lower than expected maraviroc concentrations in cerebrospinal fluid exceed the wild-type CC chemokine receptor 5-tropic HIV-1 50% inhibitory concentration. AIDS. 2012 ;26(7):890-3.
Mitochondrial DNA variation and HIV-associated sensory neuropathy in CHARTER. J Neurovirol. 2012 ;18(6):511-20.
Therapeutic amprenavir concentrations in cerebrospinal fluid. Antimicrob Agents Chemother. 2012 ;56(4):1985-9.
A conserved determinant in the V1 loop of HIV-1 modulates the V3 loop to prime low CD4 use and macrophage infection. J Virol. 2011 ;85(5):2397-405.
. HIV-1 Tat-mediated induction of platelet-derived growth factor in astrocytes: role of early growth response gene 1. J Immunol. 2011 ;186(7):4119-29.
. HIV-associated neurocognitive disorders: is there a hidden epidemic?. AIDS. 2010 ;24(9):1367-70.
. Human immunodeficiency virus type 1 in the central nervous system leads to decreased dopamine in different regions of postmortem human brains. Journal of Neurovirology [Internet]. 2009 ;15(3):257-274. Available from: http://link.springer.com/article/10.1080%2F13550280902973952
. SMAD proteins of oligodendroglial cells regulate transcription of JC virus early and late genes coordinately with the Tat protein of human immunodeficiency virus type 1. The Journal of General Virology [Internet]. 2009 ;90:2005-2014. Available from: http://www.ncbi.nlm.nih.gov/pubmed/19420158
. Clinicopathologic correlates of hepatitis C virus in brain: a pilot study. Journal of Neurovirology [Internet]. 2008 ;14:17-27. Available from: http://www.ncbi.nlm.nih.gov/pubmed/18300072
. HIV-1 Antigens in Neurons of Cocaine-Abusing Patients. Journal of Neurovirology [Internet]. 2008 ;2:24-31. Available from: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2678818/
Human immunodeficiency virus (HIV) infects human arterial smooth muscle cells in vivo and in vitro: implications for the pathogenesis of HIV-mediated vascular disease. The American Journal of Pathology [Internet]. 2008 ;172:1100-11. Available from: http://www.ncbi.nlm.nih.gov/pubmed/18310503
. Human immunodeficiency virus protease inhibitors and risk for peripheral neuropathy. Ann Neurol. 2008 ;64(5):566-72.
STAT1 signaling modulates HIV-1-induced inflammatory responses and leukocyte transmigration across the blood-brain barrier. Blood [Internet]. 2008 ;111:2062-72. Available from: http://www.ncbi.nlm.nih.gov/pubmed/18003888
.